Opioid Withdrawal at Home: What Is Safe, What Is Not, and When to Go to the ER
Dehydration, medetomidine in the fentanyl supply, and overdose after tolerance drops are what make an unplanned home withdrawal risky; the withdrawal itself is rarely fatal. Comfort medicines ease symptoms without treating the disorder, and high-dose loperamide can cause fatal heart rhythm problems. ASAM recommends buprenorphine or methadone over waiting it out.
Updated 15 sourcesLeer en español
Published by DetoxNJ.comHow we check facts
If someone may have overdosed
Call 911 if a person:
- Is very hard to wake
- Is breathing slowly or not at all
- Has blue or gray lips
- Has pinpoint pupils
If the person will not wake or is breathing slowly, treat it as an opioid overdose, even if no one thinks opioids were used:
- Call 911.
- Give naloxone (Narcan) if you have it, even if xylazine may be involved.
- If they do not wake up, give another dose every 2 to 3 minutes, as the package directs.
- Lay them on their side.
- Stay until help arrives, even if they wake up.
- Keep watching their breathing.
New Jersey’s Overdose Prevention Act protects both a caller who seeks medical help in good faith and the person who overdosed from arrest, charges, prosecution and conviction for simple possession, use and paraphernalia offenses when the evidence comes from seeking that help. It does not cover selling.
Withdrawal also needs 911 when it comes with a seizure, chest pain, confusion, a racing heart that will not settle, or vomiting that will not stop. For a mental health or suicide crisis without a medical emergency, call or text 988.
Can you go through opioid withdrawal at home?
People do, and the withdrawal itself is rarely what kills them. MedlinePlus calls opioid withdrawal very uncomfortable but not life threatening, and names home withdrawal, with medicines and a strong support system, as one setting. It also calls that method difficult and says withdrawing on your own can be dangerous.
The danger sits on either side of the withdrawal. During it, vomiting and diarrhea can dehydrate a person, and with today’s fentanyl supply, a sedative called medetomidine can cause a withdrawal of its own that needs a hospital. After it, tolerance drops within days, so a return to a former dose can be an overdose. A plan for “at home” has to answer both.
| Reasonable at home, with a clinician involved | Not safe at home |
|---|---|
| Starting buprenorphine at home on a clinician’s instructions (ASAM calls home starts safe and effective) | Starting buprenorphine on your own with pills from a friend, especially after fentanyl |
| Prescribed comfort medicines taken as labeled | Large doses of over-the-counter loperamide (Imodium) to blunt withdrawal |
| A clinic-run methadone or buprenorphine taper | Stopping cold while also stopping alcohol or benzodiazepines |
| Fluids, rest, someone checking in, naloxone in the house | Withdrawing alone, or with no plan for the days after |
Who should not try it at home
Pregnancy, street fentanyl, alcohol or benzodiazepine use, or heart disease means withdrawal should start with a clinician, not alone at home. Each changes the risk in a specific way:
- Pregnancy. Do not stop opioids on your own, and do not wait out withdrawal at home. Call the prenatal provider the same day, or go to a hospital if withdrawal has already started. ASAM recommends treatment with methadone or buprenorphine, started as early as possible, rather than withdrawal for pregnant people who are physically dependent on opioids. See detox while pregnant.
- Alcohol or benzodiazepines. Withdrawal from these can cause seizures. Our guides to alcohol at home and Ativan withdrawal explain why.
- Heart disease. Lofexidine and clonidine lower blood pressure and pulse, high-dose loperamide can disturb heart rhythm, and medetomidine withdrawal can bring a fast heart rate and severe high blood pressure.
- Fentanyl bought on the street. New Jersey’s Commission of Investigation reports that illicit fentanyl is now frequently mixed with xylazine or medetomidine, which the buyer cannot see, and the CDC warns medetomidine withdrawal can need emergency or intensive care. Start with a clinician, not alone. Our fentanyl withdrawal guide explains why.
How long opioid withdrawal lasts
Symptoms usually start within 12 hours of the last heroin use and within 30 hours of the last methadone dose, per MedlinePlus. SAMHSA’s TIP 63 puts acute withdrawal at about 7 to 10 days for short-acting opioids and 14 days or more for long-acting ones such as methadone. Early symptoms are anxiety, agitation, muscle aches, watery eyes, runny nose, sweating, yawning and insomnia; later ones are cramps, diarrhea, goosebumps, dilated pupils, nausea and vomiting. Fentanyl can stretch and blur that pattern; our heroin withdrawal timeline explains how.
Comfort medicines for opioid withdrawal, in plain terms
These ease symptoms. None of them treats the opioid use disorder underneath, and none should come from someone else’s cabinet.
| Medicine | What it does | What the source warns |
|---|---|---|
| Lofexidine (Lucemyra), prescription | FDA-approved to ease opioid withdrawal symptoms in adults, for up to 14 days | Can lower blood pressure and pulse and cause fainting; stopping it abruptly can raise blood pressure sharply. Its label says it is not a treatment for opioid use disorder. |
| Clonidine, prescription | Used off-label; MedlinePlus says it helps with anxiety, agitation, muscle aches, sweating, runny nose and cramping | Does not reduce cravings, per MedlinePlus. A related drug to lofexidine; see clonidine vs Klonopin. |
| Medicines for vomiting, diarrhea and sleep | MedlinePlus lists these as part of withdrawal treatment | Ask the prescriber which ones, and how much. |
| Loperamide (Imodium), over the counter | Approved for diarrhea | The FDA warns that much higher than labeled doses, which some people take to treat opioid withdrawal, can cause severe heart rhythm problems and death. The maximum approved adult dose is 8 mg a day over the counter. |
ASAM’s guideline says lofexidine and clonidine are safe and effective for opioid withdrawal, and then adds the part that matters most: methadone and buprenorphine are more effective at reducing symptoms, keeping people in withdrawal management, and getting them through it. The lofexidine label was tested in inpatient settings where vital signs were checked before each dose, and it tells patients to stay hydrated and to know the signs of low blood pressure.
Why starting buprenorphine beats waiting it out
Waiting out opioid withdrawal ends with lower tolerance and the same disease; starting buprenorphine ends the withdrawal and treats the disease. ASAM recommends methadone or buprenorphine for withdrawal over abrupt cessation, because a sudden stop can bring strong cravings and acute withdrawal that put the person at risk for relapse, overdose and overdose death. It says withdrawal management on its own, without ongoing treatment, is not a treatment for opioid use disorder and is not recommended.
The case for it rests on mortality. Pooled cohort studies in the BMJ (Sordo, 2017) and JAMA Psychiatry (Santo, 2021) found all-cause death rates about half as high or lower during time on methadone or buprenorphine than during time off them. The Sordo review also found sharply higher death rates in the weeks right after people leave opioid agonist treatment.
Buprenorphine is also easier to get than it used to be. Since the federal waiver was eliminated, SAMHSA says any practitioner whose DEA registration includes Schedule III authority can prescribe it for opioid use disorder where state law allows, with no patient caps. ASAM considers both office and home starts safe and effective, chosen by clinical judgment.
The one thing not to do: start it alone
Buprenorphine taken while enough fentanyl or another full opioid is still on the receptors can cause precipitated withdrawal, sudden and severe. ASAM says a standard start should wait for objective signs of withdrawal, and its 2023 clinical considerations describe other approaches clinicians use for people on fentanyl. The timing is a clinician’s call. Our Suboxone, Subutex and Sublocade guide compares the forms.
When opioid withdrawal at home becomes an ER visit
Call 911, or go to an emergency department, for any of these:
- Any opioid withdrawal during pregnancy. Go to a hospital rather than waiting it out; ASAM recommends starting methadone or buprenorphine as early as possible.
- Vomiting or diarrhea that will not stop, or signs of dehydration. MedlinePlus lists dehydration, mineral imbalances, and inhaling vomit into the lungs as complications.
- Chest pain, a racing heart that will not settle, severe high blood pressure, confusion, or drifting in and out of alertness. The CDC’s April 2026 health advisory lists chest pain, a fast heart rate, severe high blood pressure and going in and out of awareness among the signs of medetomidine withdrawal, which can need emergency or intensive care.
- Fainting or a very slow pulse on lofexidine, whose label warns of both, or fainting or an irregular heartbeat after loperamide, which the FDA says needs a 911 call.
- A seizure or hallucinations. Tell the team about any alcohol or benzodiazepine use.
- Thoughts of suicide, or a person who cannot be kept safe. MedlinePlus says anyone in opioid detox should be checked for depression.
Tell the emergency team about every substance involved, and ask whether they can start buprenorphine before you leave.
Why the days after withdrawal are the dangerous ones
Opioid withdrawal is rarely fatal by itself, but tolerance falls within days, so a return to a former dose can be fatal. The lofexidine label warns that people who complete opioid discontinuation are likely to have reduced tolerance and are at increased risk of fatal overdose if they use again, and MedlinePlus calls a return to use the biggest complication of withdrawal.
That is why a home withdrawal needs naloxone in the house before it starts. Leave it where someone can reach it, tell them where it is, and do not use alone. ASAM recommends naloxone kits for people being treated for opioid use disorder and their families. Our naloxone guide for families covers how to get it in New Jersey.
In New Jersey
Under New Jersey law P.L.2017, c.28, fully insured New Jersey plans and the State Health Benefits and School Employees’ plans cannot require prior authorization for the first 180 days per plan year of in-network treatment your own physician, psychologist or psychiatrist finds medically necessary, or, during those same 180 days, for outpatient prescription drugs that treat substance use disorder, such as buprenorphine and naltrexone, when that clinician finds them medically necessary. Self-funded employer plans, Medicare and Medicaid are not covered by that rule, so verify with the plan.
NJ FamilyCare covers buprenorphine, methadone, and naltrexone. For most NJ FamilyCare members, the state still pays opioid treatment programs directly, so ask the program, not the health plan, about methadone. Opioid treatment programs and residential care are scheduled to move into the NJ FamilyCare health plans in January 2027. The opioid detox guide lists New Jersey’s licensed opioid-capable programs, and our outpatient detox guide covers the supervised version of detoxing while living at home.
For help independent of us, the state’s IME Addictions Access Center at 1-844-276-2777 screens NJ FamilyCare and uninsured residents and refers them to treatment, and ReachNJ, the state treatment line, is at 1-844-732-2465. Periscope Behavioral Health, which publishes this site, is opening a medical detox in Hammonton, Atlantic County, expected Summer 2027. Until it opens, Periscope Behavioral Health at (888) 313-3583, our publisher’s admissions line, can talk through options in New Jersey and Florida, including facilities Periscope operates. What a plan covers depends on the plan and the facility’s network status.
Before you try it at home
Settle four things first. Has a clinician seen you, and would they start buprenorphine instead? Are alcohol, benzodiazepines or a pregnancy part of the picture? Who will stay with you, and do they know the ER signs above? And where is the naloxone, and what happens the week after the withdrawal ends?
Need help finding detox? Call the admissions line of our publisher, Periscope Behavioral Health: (888) 313-3583. Your call is treated confidentially, and insurance questions are welcome. Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777.
Frequently asked
Is it safe to detox from opioids at home?
Opioid withdrawal is rarely fatal by itself, and MedlinePlus lists home withdrawal as one setting, while calling it difficult and potentially dangerous on your own. The bigger risks are dehydration, medetomidine withdrawal in today's fentanyl supply, and overdose afterward, because tolerance falls within days. Pregnancy, street fentanyl, alcohol or benzodiazepine use, or heart disease means starting with a clinician, not alone.
What can I take for opioid withdrawal at home?
Lofexidine (Lucemyra) is FDA-approved to ease opioid withdrawal symptoms for up to 14 days, and clonidine is used off-label; both are prescription drugs that can lower blood pressure and pulse. Prescribers also treat vomiting, diarrhea and sleep. Buprenorphine or methadone works better than any of these, per ASAM. Do not take high doses of loperamide; the FDA warns it can cause fatal heart rhythm problems.
Can you take Imodium for opioid withdrawal?
Only as the label directs, for diarrhea. The FDA warns that much higher than recommended doses of loperamide, which some people take to treat opioid withdrawal, can cause severe heart rhythm problems and death. The maximum approved adult dose is 8 mg a day over the counter. Fainting or an irregular heartbeat after loperamide means calling 911.
When should you go to the ER for opioid withdrawal?
For any opioid withdrawal during pregnancy, vomiting or diarrhea that will not stop, signs of dehydration, chest pain, a racing heart that will not settle, confusion, a seizure, fainting, or thoughts of suicide. In New Jersey's fentanyl supply, the CDC warns that medetomidine withdrawal can cause a fast heart rate, severe high blood pressure and fluctuating alertness that may need intensive care.
Is it better to start Suboxone than to quit cold turkey?
Yes, per ASAM. Its guideline recommends methadone or buprenorphine over abrupt cessation, says withdrawal management alone is not a treatment for opioid use disorder, and finds buprenorphine and methadone more effective than clonidine or lofexidine for withdrawal symptoms. Death rates are about half as high or lower during time on these medicines. Start it with a clinician to avoid precipitated withdrawal.
How long does opioid withdrawal last at home?
SAMHSA's TIP 63 puts acute withdrawal at about 7 to 10 days for short-acting opioids and 14 days or more for long-acting ones such as methadone. Symptoms usually start within 12 hours of the last heroin use, per MedlinePlus. Fentanyl can make the timing less predictable.
Why is overdose risk higher after opioid withdrawal?
Tolerance falls within days, so a dose that was routine before can stop someone's breathing. The lofexidine label warns that people who complete opioid discontinuation are at increased risk of fatal overdose if they use again. Keep naloxone in the house, and do not use alone.
Request confidential help — 24/7, no obligation.
Prefer to call our publisher's admissions line, Periscope Behavioral Health?
Free state lines, 24/7: ReachNJ 1-844-732-2465 · NJ IME Addictions Access Center (Medicaid and uninsured) 1-844-276-2777
Tell us about your situation and a DetoxNJ care navigator will reach out. DetoxNJ is published by Periscope Behavioral Health, which operates or holds an ownership interest in Emerald Wellness, South Jersey Recovery Program, Palm Beach Recovery Centers, Palm Beach Healing Centers, and Transitions Recovery Program, and is developing a medical detox in Hammonton, NJ (expected Summer 2027). We make an introduction only if you ask us to.
Sources (15)
- MedlinePlus (U.S. National Library of Medicine). Opiate and opioid withdrawal (Review Date 5/15/2026).
- American Society of Addiction Medicine. National Practice Guideline for the Treatment of Opioid Use Disorder, 2020 Focused Update, executive summary (Part 3, Recommendations 1, 2, 5 and 6; Part 5, Recommendations 2 and 4; Part 8; Part 13).
- Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder.
- LUCEMYRA (lofexidine) tablets prescribing information, sections 1, 2.1, 5.1, 5.4 and 5.5 (DailyMed version July 2026). DailyMed, U.S. National Library of Medicine.
- U.S. Food and Drug Administration. FDA limits packaging for anti-diarrhea medicine loperamide (Imodium) to encourage safe use. Drug Safety Communication, January 30, 2018 (update to the June 7, 2016 communication).
- Centers for Disease Control and Prevention. Health Alert Network Health Advisory CDCHAN-00527: Medetomidine in the U.S. Illegal Fentanyl Supply Increasing Risk for Overdose and Severe Withdrawal Syndrome. April 2, 2026.
- New Jersey State Commission of Investigation. Evolving Trends and Threats in the Illicit Drug Market: Fentanyl, Veterinary Sedatives, and Other Emerging Synthetic Substances. December 2025.
- Weimer MB, et al. ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids. J Addict Med. 2023;17(6):632-639.
- Sordo L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550.
- Santo T Jr, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence. JAMA Psychiatry. 2021;78(9):979-993.
- SAMHSA. Waiver Elimination (MAT Act).
- New Jersey P.L.2017, c.28 (S3), approved February 15, 2017.
- NJ Department of Banking and Insurance. Bulletin No. 17-05: Implementation of P.L. 2017, c. 28.
- NJ DMHAS / DMAHS. End of Phase 1 Transition Period, information session for providers (August 2026): Phase 2 of behavioral health integration, SUD residential and opioid treatment programs, go-live January 2027.
- New Jersey Overdose Prevention Act, P.L.2013, c.46 (N.J.S.A. 2C:35-30, -31).